Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023

Background and aimsMetabolic reprogramming has been found to be a typical feature of tumors. Hepatocellular carcinoma (HCC), a cancer with high morbidity and mortality, has been extensively studied for its metabolic reprogramming-related mechanisms. Our study aims to identify the hotspots and fronti...

Full description

Saved in:
Bibliographic Details
Main Authors: Xia Li (Author), Liping Zhou (Author), Xinyi Xu (Author), Xiyang Liu (Author), Wenjun Wu (Author), Quansheng Feng (Author), Ziwei Tang (Author)
Format: Book
Published: Frontiers Media S.A., 2024-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_6e9a5d231ffe4bde8a64b8231ee42f9d
042 |a dc 
100 1 0 |a Xia Li  |e author 
700 1 0 |a Liping Zhou  |e author 
700 1 0 |a Xinyi Xu  |e author 
700 1 0 |a Xiyang Liu  |e author 
700 1 0 |a Wenjun Wu  |e author 
700 1 0 |a Quansheng Feng  |e author 
700 1 0 |a Ziwei Tang  |e author 
245 0 0 |a Metabolic reprogramming in hepatocellular carcinoma: a bibliometric and visualized study from 2011 to 2023 
260 |b Frontiers Media S.A.,   |c 2024-07-01T00:00:00Z. 
500 |a 1663-9812 
500 |a 10.3389/fphar.2024.1392241 
520 |a Background and aimsMetabolic reprogramming has been found to be a typical feature of tumors. Hepatocellular carcinoma (HCC), a cancer with high morbidity and mortality, has been extensively studied for its metabolic reprogramming-related mechanisms. Our study aims to identify the hotspots and frontiers of metabolic reprogramming research in HCC and to provide guidance for future scientific research and decision-making in HCC metabolism.MethodsRelevant studies on the metabolic reprogramming of HCC were derived from the Web of Science Core Collection (WoSCC) database up until November 2023. The bibliometrix tools in R were used for scientometric analysis and visualization.ResultsFrom 2011 to 2023, a total of 575 publications were obtained from WoSCC that met the established criteria. These publications involved 3,904 researchers and 948 organizations in 37 countries, with an average annual growth rate of 39.11% in research. These studies were published in 233 journals, with Cancers (n = 29) ranking first, followed by Frontiers in Oncology (n = 20) and International Journal of Molecular Sciences (n = 19). The top ten journals accounted for 26% of the 575 studies. The most prolific authors were Wang J (n = 14), Li Y (n = 12), and Liu J (n = 12). The country with the most publications is China, followed by the United States, Italy, and France. Fudan University had the largest percentage of research results with 15.48% (n = 89). Ally A's paper in Cell has the most citations. A total of 1,204 keywords were analyzed, with the trend themes such as "glycolysis," "tumor microenvironment," "Warburg effect," "mitochondria," "hypoxia ," etc. Co-occurrence network and cluster analysis revealed the relationships between keywords, authors, publications, and journals. Moreover, the close collaboration between countries in this field was elucidated.ConclusionThis bibliometric and visual analysis delves into studies related to metabolic reprogramming in HCC between 2012 and 2023, elucidating the characteristics of research in this field, which has gradually moved away from single glycolipid metabolism studies to the integration of overall metabolism in the body, pointing out the trend of research topics, and the dynamics of the interaction between the tumor microenvironment and metabolic reprogramming will be the future direction of research, which provides blueprints and inspirations for HCC prevention and treatment programs to the researchers in this field.Systematic Review Registration: [https://www.bibliometrix.org]. 
546 |a EN 
690 |a hepatocellular carcinoma 
690 |a metabolic reprogramming 
690 |a tumor microenvironment 
690 |a Warburg effect 
690 |a bibliometric 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Frontiers in Pharmacology, Vol 15 (2024) 
787 0 |n https://www.frontiersin.org/articles/10.3389/fphar.2024.1392241/full 
787 0 |n https://doaj.org/toc/1663-9812 
856 4 1 |u https://doaj.org/article/6e9a5d231ffe4bde8a64b8231ee42f9d  |z Connect to this object online.